我要投票 南京高科在房地产行业中的票数:87
· 外 推 电 报 ·
2025-01-20 16:31:44 星期一

【南京高科是哪个国家的品牌?】

南京高科是什么牌子?「南京高科」是 南京高科股份有限公司 旗下著名品牌。该品牌发源于江苏省南京市,由创始人徐董在1992年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

南京高科股份有限公司(股票简称:南京高科;股票代码:600064)是1992年7月4日经南京市经济体制改革委员会批准设立的定向募集股份有限公司,目前注册资本7.72亿元。1997年5月6日在上海证券交易所挂牌上市。公司主营:高新技术产业投资、开发;市政基础设施建设、投资及管理;土地成片开发;建筑安装工程;商品房开发、销售;物业管理;自有房屋租赁;工程设计;咨询服务;污水处理、环保项目建设、投资及管理。公司控股股东为南京新港开发总公司,实际控制人为南京市人民政府国有资产监督管理委员会。

上市20年来,公司抓住资本市场大发展的机遇,依托上市公司的品牌优势、资金优势,在立足开发区建设和经营的同时,以实现持续成长为目标,积极培育公司新的利润增长点。公司培育或投资了包括高科置业、臣功制药、南京银行、栖霞建设、中信证券、南京证券、LG新港、广州农商行等一批资产质量优良、盈利能力突出的优质企业,搭建了公司未来可持续发展的产业架构,保障了各项业务稳步增长的良好态势。公司上市后多次进行利润分配,在向股东送红股和转增股本的同时,累计分配现金红利逾19亿元,超过了公司两次募集资金总额,充分体现了公司“为股东创造价值”的经营理念。

公司董事会下设战略、审计、提名、薪酬与考核四个专业委员会,总部形成了包括办公室、人力资源部、计划财务部、投资管理部、运营管理部和审计部“一室五部”的组织架构,建立了组织架构和公司治理体系。公司旗下现有高科置业、高科建设、臣功制药、高科新创、高科科贷等7家控股子公司、13家参股子公司,产业横跨房地产、市政、医药、股权投资等多个领域,搭建了投资控股型集团公司模式。

展望未来,公司将继续秉承“整合资源、创造价值”的经营理念,在稳步发展房地产市政等传统主营业务同时,加快“大健康、大创投”的战略转型步伐,着力将公司打造成为“健康+创投”特色鲜明的上市公司,为股东创造更大的价值!


英文翻译:Nanjing High Tech Co., Ltd. (stock abbreviation: Nanjing high tech; Stock Code: 600064) is a directional raising Co., Ltd. established on July 4, 1992 with the approval of Nanjing Economic System Reform Commission. At present, its registered capital is 772 million yuan. It was listed on the Shanghai Stock Exchange on May 6, 1997. The company's main businesses include: investment and development of high-tech industry; municipal infrastructure construction, investment and management; land development; construction and installation engineering; commercial housing development and sales; property management; self owned housing leasing; engineering design; consulting services; sewage treatment, environmental protection project construction, investment and management. The controlling shareholder of the company is Nanjing Xingang Development Corporation, and the actual controller is the state owned assets supervision and Administration Commission of Nanjing Municipal People's government. In the past 20 years of listing, the company has seized the opportunity of great development of the capital market, relied on the brand and capital advantages of the listed company, and based on the construction and operation of the Development Zone, with the goal of achieving sustainable growth, actively cultivated the company's new profit growth point. The company has cultivated or invested a number of high-quality enterprises with excellent asset quality and outstanding profitability, including hi tech real estate, Chenggong pharmaceutical, Bank of Nanjing, Qixia construction, CITIC Securities, Nanjing Securities, LG new port, Guangzhou agricultural commercial bank, etc., built the company's industrial structure for sustainable development in the future, and guaranteed a good momentum of steady growth of various businesses. After the listing of the company, profit distribution has been carried out for many times. At the same time of sending bonus shares and increasing share capital to shareholders, the accumulated cash dividend has been distributed more than 1.9 billion yuan, which exceeds the total amount of funds raised by the company twice, fully reflecting the company's business philosophy of "creating value for shareholders". The company's board of Directors consists of four professional committees: strategy, audit, nomination, remuneration and assessment. The headquarters has formed an organizational structure of "one office, five departments" including the office, human resources department, planning and finance department, investment management department, operation management department and audit department, and established an organizational structure and corporate governance system. The company has 7 holding subsidiaries and 13 participating subsidiaries, including hi-tech real estate, hi-tech construction, Chenggong pharmaceutical, hi-tech innovation and hi-tech loan. The industry spans real estate, municipal administration, medicine, equity investment and other fields, and has built an investment holding group company model. Looking forward to the future, the company will continue to uphold the business philosophy of "integrating resources and creating value", while steadily developing the traditional main business such as real estate and municipal administration, accelerate the strategic transformation of "big health and big venture capital", and strive to build the company into a listed company with distinctive characteristics of "health + venture capital" to create greater value for shareholders!

本文链接: https://www.waitui.com/brand/c0e9ba0f3.html 联系电话:025-85800700

千城特选小程序码

7×24h 快讯

平安产险成立轩坤股权投资合伙企业,出资额100亿

36氪获悉,天眼查App显示,近日,嘉兴轩坤股权投资合伙企业(有限合伙)成立,执行事务合伙人为平安创赢资本管理有限公司,出资额100亿人民币,经营范围为股权投资。合伙人信息显示,该合伙企业由中国平安财产保险股份有限公司、平安创赢资本管理有限公司分别出资99.99%、0.01%。

32分钟前

闲鱼:将构建“1+N+2”的城市数字化循环流通网络

36氪获悉,近日,江苏首家闲鱼循环商店在南京熙南里街区开业,该店集闲置交易、艺术文化交流、圈层链接、产业发展等多种业态于一体,是目前面积最大、业态最丰富多元的一家闲鱼循环商店。据介绍,基于南京熙南里店,闲鱼将构建“1+N+2”的城市数字化循环流通网络,即1个循环商店中心场,N个循环站,2大循环市集协同的模式,未来还将进入全国百城,辐射上千社区。

32分钟前

豆包实时语音大模型上线

36氪获悉,豆包实时语音大模型于今日正式推出,并在豆包App全量开放,将豆包App升级至7.2.0版本即可体验。据介绍,豆包实时语音大模型,是一款语音理解和生成一体化的模型,实现了端到端语音对话。相比传统级联模式,在语音表现力、控制力、情绪承接方面表现惊艳,并具备低时延、对话中可随时打断等特性。

32分钟前

通化东宝:获依托考昔片药品注册证书

36氪获悉,通化东宝发布公告,公司于近日收到国家药品监督管理局核准签发的依托考昔片《药品注册证书》。依托考昔临床应用广泛,包括骨关节炎、原发性痛经、急性痛风性关节炎等,是中国目前唯一获批用于急性痛风性关节炎治疗的COX—2抑制剂。

32分钟前

东亚药业:卢立康唑获韩国MFDS原料药品注册证书

36氪获悉,东亚药业发布公告,公司收到韩国食品药品监督管理局(韩国MFDS)原料药品卢立康唑的注册证书。该药用于治疗敏感菌引起的皮肤浅表真菌感染,如足癣、体癣、股癣,也可用于皮肤念珠菌病和花斑癣。据相关数据显示,卢立康唑乳膏2023年度全国医院销售额约为0.24亿元,2023年度全国药店零售销售额约为0.025亿元。

32分钟前

本页详细列出关于协信SINCERE的品牌信息,含品牌所属公司介绍,协信SINCERE所处行业的品牌地位及优势。
咨询